Treating Prostate Cancer
Prostate cancer is the most common solid tumor and the second leading cause of cancer death among American men. And while a variety of treatment options exists, from surgery to radiation to cryotherapy, no single treatment works best, no single institution has the expertise to provide them all, and not every patient responds well to each therapy.
With $7.6 million in U.S. Stimulus funds from the Agency for Healthcare Research and Quality, Vanderbilt and five other clinical sites will follow 4,200 men who were diagnosed with localized prostate cancer to compare outcomes and identify the best courses of treatment.
Led by Vanderbilt University Medical Center, the “Comparative Effectiveness Analysis of Surgery and Radiation for Prostate Cancer,” or CESAR, will help physicians determine the best way to treat prostate cancer once localized, providing a scientific basis for what works best, in which patients and in whose hands.
University of Southern California
University of Southern California San Francisco
University of Medicine and Dentistry New Jersey
Louisiana State University
University of California Irvine
MD Anderson Cancer Center